Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tufia C Haddad
Alliance for Clinical Trials in Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
390 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Hospital
Mobile, Alabama, United States
- Mayo Clinic in Arizona
Scottsdale, Arizona, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills-Peninsula Medical Center
Burlingame, California, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- Eden Hospital Medical Center
Castro Valley, California, United States
- Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Valley Medical Oncology Consultants-Fremont
Fremont, California, United States
- Glendale Memorial Hospital and Health Center
Glendale, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- El Camino Hospital
Mountain View, California, United States
- Palo Alto Medical Foundation-Camino Division
Mountain View, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Tom K Lee Inc
Oakland, California, United States
- Desert Regional Medical Center
Palm Springs, California, United States
- Palo Alto Medical Foundation Health Care
Palo Alto, California, United States
- Valley Care Health System - Pleasanton
Pleasanton, California, United States
- Valley Medical Oncology Consultants
Pleasanton, California, United States
- Salinas Valley Memorial
Salinas, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Doctors Medical Center- Jc Robinson Regional Cancer Center
San Pablo, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Kaiser Permanente-Franklin
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Scl Health Saint Joseph Hospital
Denver, Colorado, United States
- Western States Cancer Research Ncorp
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Saint Mary'S Hospital and Regional Medical Center
Grand Junction, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jul 2008
- Primary completion
- 7 Jan 2014
- Completion
- 15 Oct 2019
- Last update posted
- 24 Mar 2020
- Registered enrollment
- 64
- Registry id
- NCT00684983
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.